跳至主要内容
临床试验/CTRI/2023/08/056877
CTRI/2023/08/056877尚未招募4 期

Daily oral v/s weekly intramuscular vitamin B12 supplementation for nutritional megaloblastic anemia in children aged 5-14 years: An open labelled Randomized Controlled Trial - nil

o sponsorship0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Children aged 5-14 years
  • 2. Any of the clinical features with suspected megaloblastic anemia like pallor, hyperpigmentation of knuckles
  • 3. Laboratory parameters suggestive of megaloblastic anemia with peripheral smear showing macrocytic red blood cells, hypersegmented neutrophils or thrombocytopenia or
  • 3. Mean corpuscular volume > 90 fL or
  • 4. Documented serum Vitamin B12 levels <100 pg/mL will be enrolled

排除标准

  • 1. Children on drugs likely to cause peripheral blood megaloblastosis like Phenytoin/Valproate and chemotherapeutic drugs like Methotrexate
  • 2. Hemodynamically unstable children
  • 3. Children already on any form of vitamin B12 supplementation for more than 2 weeks
  • 4. Patients with chronic gastrointestinal disorders/ malabsorption like coeliac disease, inflammatory bowel disease, short bowel syndrome or surgical causes.
  • 5. Patient/caregivers not giving consent

研究者

发起方
o sponsorship

相似试验

Oral vs intramuscular administration of vitamin B12... | 临床试验